Grant: CAG/CCFC/CIHR Summer Studentship for Research in Gastroenterology
University of British Columbia
$3,000.00
The Role of Retinoic Acid in Intestinal Immunity and Inflammation.
EF 2008-09
Résumé
Inflammation of the gastrointestinal (GI) tract is a major cause of disease and death in
Canada and the world. There are presently over 200,000 Canadians suffering from a
form of inflammatory bowl disease (IBD). In addition, on average, 413 Canadians will be
diagnosed with colorectal cancer every week and 171 will die from the disease weekly,
the second-leading cause of cancer death in Canada. In the developing world, gut
infections such as cholera, amoebic dysentery and parasitic helminthes are the leading
causes of disease and death. Given these statistics, there is an impetus for researchers to
focus their efforts towards identifying new treatments and methods to treat inflammatory
disorders of the gut while understanding how to promote effective immune responses.
Retinoic Acid (RA) is a molecule that is synthesized from Vitamin A in the gut. This study
will examine the role of RA in regulation of immunity and inflammation. The aims of this
study will be to determine which cells are responsible for the synthesis of RA and to
determine how other cells respond to RA. Identifying the factors that regulate the cells
and molecules associated with inflammation in the gut will lead to better diagnosis and
treatment of intestinal inflammation and may be useful commercially for detection,
monitoring, or screening of IBDs. In addition, by identifying the mechanisms required for
optimal immunity to infection, the development and optimization of vaccines against
deadly intestinal diseases will not only benefit developing nations but will also highlight
Canada¿s important role in global public health initiatives.
Programme
CAG/CCFC/CIHR Summer Studentship for Research in Gastroenterology
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
182293
Name
Burrows Kyle
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
CIHR - INMD - CAG (Canadian Association of Gastroenterology) Partnership
Projecttitle
The Role of Retinoic Acid in Intestinal Immunity and Inflammation.
Programtype2
Summer Student Programs
Orgnameinp2
University of British Columbia
Cihramount2
$3,000
Cihrequipment2
$0
Programname2
CAG/CCFC/CIHR Summer Studentship for Research in Gastroenterology
Keyworddelim
Immunity; Inflammation; Inflammatory Bowel Disease; Retinoic Acid
Abstract
Inflammation of the gastrointestinal (GI) tract is a major cause of disease and death in
Canada and the world. There are presently over 200,000 Canadians suffering from a
form of inflammatory bowl disease (IBD). In addition, on average, 413 Canadians will be
diagnosed with colorectal cancer every week and 171 will die from the disease weekly,
the second-leading cause of cancer death in Canada. In the developing world, gut
infections such as cholera, amoebic dysentery and parasitic helminthes are the leading
causes of disease and death. Given these statistics, there is an impetus for researchers to
focus their efforts towards identifying new treatments and methods to treat inflammatory
disorders of the gut while understanding how to promote effective immune responses.
Retinoic Acid (RA) is a molecule that is synthesized from Vitamin A in the gut. This study
will examine the role of RA in regulation of immunity and inflammation. The aims of this
study will be to determine which cells are responsible for the synthesis of RA and to
determine how other cells respond to RA. Identifying the factors that regulate the cells
and molecules associated with inflammation in the gut will lead to better diagnosis and
treatment of intestinal inflammation and may be useful commercially for detection,
monitoring, or screening of IBDs. In addition, by identifying the mechanisms required for
optimal immunity to infection, the development and optimization of vaccines against
deadly intestinal diseases will not only benefit developing nations but will also highlight
Canada¿s important role in global public health initiatives.
Competitiondate
200902
Approvedterm2
0 yr 4 mths
Pinamesdelim
Burrows, Kyle
Approvedterm
0 an 4 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $3,000~ $0~